Floris Barthel

Postdoctoral Associate

Deploys next-generation sequencing techniques to understand brain tumor biology and telomere mechanics

Visit The Verhaak Lab

About Floris Barthel, M.D.

Dr. Barthel received his M.D. degree from the Vrije Universiteit Amsterdam prior to joining the MD Anderson Cancer Center in Houston to pursue a postdoctoral position in glioma genomics. He research is focused on transcriptional and epigenetic profiling of gliomas and in understanding the genomic basis of telomere maintenance in cancer.

Education and Experience

2016-present: Postdoctoral Associate. The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut.

2014-2016: Senior Research Assistant. MD Anderson Cancer Center, Houston, Texas.

2007-2014: M.D., Medicine. Vrije Universiteit Amsterdam, The Netherlands.

Research HighlightJune 21, 2018
Finding the genes controlling ovarian reserve could hold key to better female fertility care
Jackson Laboratory Assistant Professor Ewelina Bolcun-Filas, Ph.D., is looking at how multiple genetic factors regulating oocyte development determine the differences in each woman’s ovarian reserve.
Tech CornerMay 04, 2018
What's new in cancer research?
The field of cancer immunotherapy research is extremely exciting, yet still somewhat mysterious, as researchers grapple with the fine-tuning of patient response.
- Cancer/Tumors
- Cancer
Search MagazineApril 27, 2018
Finding precise cures for cancer
At JAX's new speaker event series, JAXtaposition, two scientific leaders shared how the Maine Cancer Genomics Initiative and JAX’s cutting-edge genomic testing is giving physicians access to the most advanced precision cancer care for their patients.
- Cancer/Tumors
- Cancer
Research HighlightApril 10, 2018
Cancer research: Beyond the Petri dish
The latest developments in cancer research and their translation to oncology practice offer truly exciting potential for better therapies in the near future.

Research HighlightJune 11, 2018
Measuring tumor heterogeneity for better, evolution-based cancer treatment strategies
JAX Associate Professor Jeffrey Chuang, Ph.D., has been awarded a five-year grant totaling $2,650,484 from the National Cancer Institute for research that could pave the way for the first evolution-based approaches to cancer treatment.
- Cancer/Tumors
- Cancer
Press ReleaseApril 30, 2018
Detecting human genome structural variation with long read sequencing
A research team led by Chia-lin Wei is using technology to more easily detect and classify important types of difficult-to-find genomic alterations, known as structural variants.
- Genetic Tools
- Genetics and Genomics
Press ReleaseApril 23, 2018
The role of extra DNA in cancer evolution and therapy resistance
New research is providing a better understanding of the processes underlying cell-to-cell differences within glioblastoma tumors — a crucial finding because these differences contribute to therapy resistance.
- Cancer/Tumors
- Cancer
Tech CornerApril 10, 2018
Cancer and its immune environment bioprinted and reproduced live and in 3D
New 3D bioprinting technique creates a platform for precision immunotherapy study.

Floris Barthel, M.D.

Postdoctoral Associate

About Floris Barthel, M.D.

Selected Publications